Oculis Holding AG (OCS) Tax Provisions (2022 - 2026)
Oculis Holding AG (OCS) recorded quarterly Tax Provisions of $125146.5 in Q1 2026, up 100.12% quarter-over-quarter from -$102.4 million in Q4 2025, and up 1707.38% on a YoY basis from $6924.2 in Q1 2025.
Oculis Holding AG (OCS) Tax Provisions (2022 - 2026) Analysis & Trends
Oculis Holding AG's Tax Provisions history runs 5 years deep, the most recent figure standing at $125146.5 for Q1 2026.
- In Q1 2026, Tax Provisions rose 1707.38% year-over-year to $125146.5; the TTM figure through Mar 2026 stood at -$118.5 million (down 476.59% YoY), while the FY2025 annual figure was $232717.6, up 27.42% from the prior year.
- Tax Provisions was $125146.5 for Q1 2026 at Oculis Holding AG, up from -$102.4 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $271682.2 in Q4 2024 to a low of -$102.4 million in Q4 2025.
- Historically, Tax Provisions has averaged -$8.7 million across 5 years, with a median of -$20479.8 in 2024.
- The sharpest annual moves came in 2023 and 2025: Tax Provisions jumped 2213.88% in 2023, then slumped 37777.55% in 2025.
- A 5-year view of Tax Provisions shows it stood at $14532.3 in 2022, then increased by 0.85% to $14655.6 in 2023, then surged by 1753.78% to $271682.2 in 2024, then plunged by 37777.55% to -$102.4 million in 2025, then jumped by 100.12% to $125146.5 in 2026.
- The last three Tax Provisions figures came in at $125146.5 (Q1 2026), -$102.4 million (Q4 2025), and -$16.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | 125,146.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125,146.46 |
| Dec 31, 2025 | -102.36 Mn |
| Sep 30, 2025 | -16.25 Mn |
| Jun 30, 2025 | 28,989.37 |
| Mar 31, 2025 | -7,785.75 |
| Dec 31, 2024 | 271,682.20 |
| Sep 30, 2024 | -20.78 Mn |
| Jun 30, 2024 | -33,173.80 |
| Mar 31, 2024 | -34,370.47 |
| Dec 31, 2023 | 14,655.61 |
| Sep 30, 2023 | 131,329.70 |
| Jun 30, 2023 | -126,788.01 |
| Mar 31, 2023 | -134,064.16 |
| Dec 31, 2022 | 14,532.31 |
| Sep 30, 2022 | -6,212.74 |
| Jun 30, 2022 | -43,608.31 |